OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above 200 Day Moving Average – Here’s What Happened

OraSure Technologies, Inc. (NASDAQ:OSUR)’s share price crossed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $3.68 and traded as high as $4.13. OraSure Technologies shares last traded at $3.77, with a volume of 534,071 shares changing hands.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Zacks Research upgraded shares of OraSure Technologies to a “hold” rating in a research note on Friday, October 2nd. Wall Street Zen upgraded OraSure Technologies from a “sell” rating to a “hold” rating in a research report on Monday, August 10th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of OraSure Technologies in a report on Tuesday, September 1st. Two research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Reduce” and an average price target of $3.00.

OraSure Technologies Stock Up 1.9%

The firm has a market capitalization of $262.09 million, a P/E ratio of -5.51 and a beta of 1.03. The business’s 50 day moving average is $3.76 and its two-hundred day moving average is $3.68.

Institutional Trading of OraSure Technologies

Institutional investors have recently made changes to their positions in the stock. Hsbc Holdings PLC raised its holdings in shares of OraSure Technologies by 4.6% during the 1st quarter. Hsbc Holdings PLC now owns 141,309 shares of the medical instruments supplier’s stock valued at $421,000 after purchasing an additional 6,218 shares in the last quarter. Legal & General Group Plc acquired a new stake in shares of OraSure Technologies in the second quarter worth about $30,000. Diversify Advisory Services LLC bought a new stake in shares of OraSure Technologies during the 2nd quarter worth about $47,000. Diversify Wealth Management LLC bought a new position in shares of OraSure Technologies in the 1st quarter valued at approximately $36,000. Finally, Two Sigma Securities LLC acquired a new stake in OraSure Technologies in the 2nd quarter worth approximately $55,000. 93.50% of the stock is owned by institutional investors and hedge funds.

OraSure Technologies Company Profile

OraSure Technologies, Inc develops and manufactures diagnostic products, specimen collection devices, and molecular testing solutions. The company’s offerings are designed for use by consumers, healthcare providers, laboratories, public health organizations, and research customers, with an emphasis on convenient and less-invasive sample collection and testing.

OraSure is best known for its OraQuick portfolio, which has included rapid tests for HIV and hepatitis C that use oral-fluid or finger-stick samples.